EUVIMEDEUVIMED entdecken
Crossref

Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B

David E Schmidt, Åsa Truedsson, Annelie Strålfors, Johanne Andersen Hojbjerg, Nida Soutari, Margareta Holmström, Susanna Ranta, Anna Letelier, Annette Bowyer, Rolf Ljung, Jovan Antovic, Maria Bruzelius

Thrombosis and Haemostasis · 01.01.2024 · 124 (01) · 032-039

DOI: 10.1055/a-2142-0262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.01.2024. Verfasst von David E Schmidt und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Hemophilia B, Hemophilia A. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Studienstiftung des Deutschen Volkes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Discrepancy in factor IX activity (FIX:C) between one-stage assay (OSA) and chromogenic substrate assay (CSA) in patients with hemophilia B (PwHB) introduces challenges for clinical management.

Aim

To study the differences in FIX:C using OSA and CSA in moderate and mild hemophilia B (HB), their impact on classification of severity, and correlation with genotype.

Methods

Single-center study including 21 genotyped and clinically characterized PwHB. FIX:C by OSA was measured using ActinFSL (Siemens) and CSA by Biophen (Hyphen). In addition, in vitro experiments with wild-type FIX were performed. Reproducibility of CSA was assessed between three European coagulation laboratories.

Results

FIX:C by CSA was consistently lower than by OSA, with 10/17 PwHB having a more severe hemophilia type by CSA. OSA displayed a more accurate description of the clinical bleeding severity, compared with CSA. A twofold difference between OSA:CSA FIX:C was present in 12/17 PwHB; all patients had genetic missense variants in the FIX serine protease domain. Discrepancy was also observed with diluted normal plasma, most significant for values below 0.10 IU/mL. Assessment of samples with low FIX:C showed excellent reproducibility of the CSA results between the laboratories.

Conclusion

FIX:C was consistently higher by OSA compared with the CSA. Assessing FIX:C by CSA alone would have led to diagnosis of a more severe hemophilia type in a significant proportion of patients. Our study suggests using both OSA and CSA FIX:C together with genotyping to classify HB severity and provide essential information for clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia BHemophilia AHumansFactor IXReproducibility of ResultsBlood CoagulationBlood Coagulation Tests

Substanzen

Factor IX

Autor:innen und Institutionen

  • Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Paediatric Coagulation, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Förderung

  • Studienstiftung des Deutschen Volkes

Zitieren

APA

Schmidt, D. E., Truedsson, Å., Strålfors, A., Hojbjerg, J. A., Soutari, N., Holmström, M., Ranta, S., Letelier, A., Bowyer, A., Ljung, R., Antovic, J., & Bruzelius, M. (2024). Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B. Thrombosis and Haemostasis, 124(01), 032-039. https://doi.org/10.1055/a-2142-0262

Vancouver

Schmidt DE, Truedsson Å, Strålfors A, Hojbjerg JA, Soutari N, Holmström M, et al. Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B. Thrombosis and Haemostasis. 2024;124(01):032-039. doi:10.1055/a-2142-0262

BibTeX
@article{Schmidt2024,
  author = {Schmidt, David E and Truedsson, Åsa and Strålfors, Annelie and Hojbjerg, Johanne Andersen and Soutari, Nida and Holmström, Margareta and Ranta, Susanna and Letelier, Anna and Bowyer, Annette and Ljung, Rolf and Antovic, Jovan and Bruzelius, Maria},
  title = {Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B},
  journal = {Thrombosis and Haemostasis},
  year = {2024},
  volume = {124},
  number = {01},
  pages = {032--039},
  doi = {10.1055/a-2142-0262}
}
Kostenlos starten →